2017-07-01
End-of-life medical spending in last twelve months of life is lower than previously reported
Publication
Publication
Health Affairs: the policy journal of the health sphere , Volume 36 - Issue 7 p. 1211- 1217
Although end-of-life medical spending is often viewed as a major component of aggregate medical expenditure, accurate measures of this type of medical spending are scarce. We used detailed health care data for the period 2009–11 from Denmark, England, France, Germany, Japan, the Netherlands, Taiwan, the United States, and the Canadian province of Quebec to measure the composition and magnitude of medical spending in the three years before death. In all nine countries, medical spending at the end of life was high relative to spending at other ages. Spending during the last twelve months of life made up a modest share of aggregate spending, ranging from 8.5 percent in the United States to 11.2 percent in Taiwan, but spending in the last three calendar years of life reached 24.5 percent in Taiwan. This suggests that high aggregate medical spending is due not to last-ditch efforts to save lives but to spending on people with chronic conditions, which are associated with shorter life expectancies.
| Additional Metadata | |
|---|---|
| doi.org/10.1377/hlthaff.2017.0174, hdl.handle.net/1765/100769 | |
| Health Affairs: the policy journal of the health sphere | |
| Organisation | Erasmus School of Health Policy & Management (ESHPM) |
|
French, E.B., McCauley, J. W., Aragon, M, Bakx, P., Chalkley, M, Chen, SH, … Kelley, E. (2017). End-of-life medical spending in last twelve months of life is lower than previously reported. Health Affairs: the policy journal of the health sphere, 36(7), 1211–1217. doi:10.1377/hlthaff.2017.0174 |
|